FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/03/2025
Voltar para busca
Dado oficial do USPTO
LUNGCLEAR
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
LUNGCLEAR
ST13
US500000079366536Classe
5, 10, 44
Pedido
79366536
Registro
7477128
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
22
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10, 44
Data de depósito
18/01/2023
Data de registro
20/08/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
20/08/2024
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
24
Localização do titular
SG
Examinador
CANTOR, JILLIAN REDDING
Unidade examinadora
M80
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
MIRXES PTE. LTD.
Representantes
Joseph G. Chu JCIP
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Diagnostic preparations for medical and veterinary use or purposes; Medical diagnostic reactants for medical and veterinary diagnosis of diseases; diagnostic preparations for medical use for sale in kit form; diagnostic preparations for medical purposes; Biological indicators for medical diagnosisfor detecting and diagnosing cancer; veterinary diagnostic reagents; Diagnostic reagents in kit form for conducting molecular biology assays for medical and veterinary purposes; Diagnostic reagents for medical and veterinary purposes; Diagnostic reagents for use in diagnostic tests for medical and veterinary purposes; pharmaceutical preparations for the treatment of disorders of the metabolic system; medical diagnostic reagents for testing of body fluids; Medical diagnostic assays that test for genetic anomalies for medical use; Diagnostic preparations for medical use; Biochemical preparations for diagnostic use for detecting and diagnosing cancer; Diagnostic preparations for medical purposes; diagnostic agents for pharmaceutical use in the medical field; Test reagents for medical diagnosisdisease testing; diagnostic biomarker reagents for medical purposes; Chemical preparations for diagnostic medical purposesfor detecting and diagnosing cancer; Chemical preparations for use in medical diagnosticsnucleic acid analysis; Chemical preparations for detecting genetic and epigenetic predispositions for medical purposes; Medical diagnostic reagents for analysis of body fluids; Synthetic deoxyribonucleic acid and synthetic ribonucleic acid for medical usefor detecting and diagnosing cancer; nucleic acid amplification reagents for medical use
Classe 10
Medical diagnostic apparatus for detecting and diagnosing cancer; Medical diagnostic instruments for analysis of body fluids; Biomedical testing apparatus for RNADNA and protein biomarkers testing; Medical diagnostics instruments in the nature of apparatus for testing RNADNA and protein biomarkers; medical instruments for infectious disease testing; Medical diagnostic testing apparatus for sale in kit form for testing RNADNA and protein biomarkers for diagnosing and detecting cancer; Medical diagnostic apparatus for testing RNADNA and protein biomarkers for diagnosing and detecting cancer; Diagnostic in-vitro diagnostic testing apparatus for medical use for diagnosing and detecting cancer; Medical diagnostic testing apparatus for use in molecular biology procedurestesting DNARNA and protein biomarkers for diagnosing and detecting cancer; Diagnostic apparatus for blood tests for medical use
Classe 44
Medical diagnostic servicestesting and analysis; medical testing services relating to the diagnosis and treatment of disease; medical analysis services for the diagnosis of cancer; Medical servicesnucleic acid analysis for cancer diagnosis and prognosis; performing diagnosis of diseases; medical services for the diagnosis of conditions of the human body; genetic testing of animals for diagnostic or treatment purposes; medical laboratory services related to the treatment of patients; Medical advisory services in the field of oncological diseases; medical analysis for the diagnosis and treatment of persons; Medical serviceshealth risk assessment surveys; health-care services for treating and detecting cancer; genetic testing for medical purposes; Medical servicesnucleic acid screening for medical purposes; Medical analysis services for diagnosing and detecting cancer; medical screening; Health screening services in the field of cancer
Publicações
Histórico de despachos e eventos da marca no USPTO.
22 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/02/2025
FIMP
FINAL DISPOSITION PROCESSED
10/02/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
20/11/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
20/08/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
20/08/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/06/2024
PUBO
PUBLISHED FOR OPPOSITION
04/06/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
15/05/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
30/04/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
26/04/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/04/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
26/04/2024
RFNT
REFUSAL PROCESSED BY IB
22/11/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
27/10/2023
RFRR
REFUSAL PROCESSED BY MPU
27/10/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
20/10/2023
CNRT
NON-FINAL ACTION WRITTEN
19/10/2023
DOCK
ASSIGNED TO EXAMINER
17/10/2023
MAFR
APPLICATION FILING RECEIPT MAILED
07/04/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/04/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
31/03/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LUNGCLEAR ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.